Expert Rev Mol Diagn. 2008;8(5):579-585. Quite a few tumor markers (CEA, CA 19-9, AFP, SCC, CA 72-4.) have already been established in diagnosis and/or surveillance of malignant diseases of the GI ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO ...

This poster highlights the potential of STC-1010 to induce a robust anti-tumor response ... This press release is not a document produced by AFP. AFP shall not bear responsibility for its content.

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer ...

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood, developed by Johns Hopkins Kimmel Cancer Center investigators, could help ...

With most solid tumors, the estimation of life expectancy is related to tumor stage at diagnosis and staging is directly linked to treatment indication. By contrast, in patients with ...